Cipla quarterly results

Q2 FY27 · Jul–Sep 2026
₹ croreQ2 FY27Q2 FY26Change
Revenue7,4047,589−2.4%
EBITDA1,3881,895−26.8%
EBITDA margin18.7%25.0%−6.2 pts
Profit before tax1,1771,854−36.5%
Net profit8521,353−37.1%
EPS₹10.86₹16.73−35.1%

Every quarter

₹ crore except per share
Tap a line for its trendQ2 FY27Sep 2026Q1 FY27Jun 2026Q4 FY26Mar 2026Q3 FY26Dec 2025Q2 FY26Sep 2025Q1 FY26Jun 2025Q4 FY25Mar 2025Q3 FY25Dec 2024Q2 FY25Sep 2024Q1 FY25Jun 2024Q4 FY24Mar 2024Q3 FY24Dec 2023Earlier quartersAlpha Plus
7,4047,1196,5417,0747,5896,9576,7307,0737,0516,6946,1636,604
Earlier quartersEvery year the company has filed comes with Alpha Plus.
151211148206269259289222191160249185
7,5557,3306,6897,2817,8587,2167,0197,2957,2426,8546,4136,788
Expenses
1,5241,3571,3821,4621,5281,4691,3981,2971,4741,2411,2531,196
1,3131,2521,2851,2498931,0251,0249138151,100739927
−20358.6−418−78.576.5−324−23354.1−5.6−14858.596.1
1,4751,4971,4141,3251,3151,3121,2331,1981,2081,1941,0841,068
16.717.013.114.013.214.114.014.615.418.017.630.1
345304383278297253309280272247288233
1,9081,7621,9231,8621,8821,6961,7701,6221,6751,5911,7131,569
6,3786,2485,9826,1126,0055,4465,5155,3785,4535,2435,1535,120
1,3881,1929551,2551,8951,7781,5381,9891,8861,7161,3161,748
1,0438885729771,5981,5251,2291,7091,6141,4691,0281,514
Profit
1,1771,0827071,1691,8541,7701,5041,9161,7891,6111,2591,669
0.00.00.0−2760.00.00.00.00.00.00.0−195
1,1771,0827078931,8541,7701,5041,9161,7891,6111,2591,474
372393282161468530480338459431511330
−51.5−98.0−12557.732.1−51.7−201−5.324.03.8−18675.6
321295157219500478279332483435325405
−5.0−1.6−7.6−0.30.3−0.4−10.9−9.1−1.0−0.8−2.5−0.1
8527865436741,3531,2921,2141,5751,3051,1759321,068
8577875506751,3531,2921,2251,5841,3061,1769341,069
13419413620426681.454.5−37.713170.7−79.52.4
9869806788781,6201,3731,2691,5371,4361,2468521,071
8787895556761,3511,2981,2221,5711,3031,1789391,056
−26.0−3.5−12.1−1.62.2−6.0−7.74.12.5−2.2−7.212.5
Per share
₹10.86₹9.77₹6.87₹8.37₹16.73₹16.07₹15.13₹19.45₹16.13₹14.58₹11.63₹13.08
₹10.85₹9.76₹6.86₹8.36₹16.72₹16.06₹15.12₹19.43₹16.12₹14.57₹11.62₹13.07
Other comprehensive income — detail
13419413620426681.454.5—————
−2.024.3−178−2.4−0.0−8.5−52.3−1.6−6.0−6.2−52.7−1.5
−0.56.10.7−0.6−0.0−2.2−6.5—————
———————−0.4−1.5−1.5−18.0−0.4
14618930220423686.1113−31.812372.4−43.32.5
10.312.8−12.5−2.3−30.0−1.712.8—————
———————4.7−13.2−3.11.5−1.1
1,0139836928801,6171,3791,2751,5331,4331,2498601,057
−27.0−3.0−13.8−1.32.4−5.8−6.23.73.2−2.4−7.713.8
Per share — as-filed variants
₹10.86₹9.77₹6.87₹8.37₹16.73₹16.07₹15.13₹19.45₹16.13₹14.58₹11.63₹13.08
₹10.85₹9.76₹6.86₹8.36₹16.72₹16.06₹15.12₹19.43₹16.12₹14.57₹11.62₹13.07
Derived — gross profit (revenue − materials − purchases − Δ inventories)
4,7704,4524,2934,4425,0924,7874,5414,8094,7684,5014,1134,384
64.4%62.5%65.6%62.8%67.1%68.8%67.5%68.0%67.6%67.2%66.7%66.4%
Adjusted (ex-exceptional items) — derived
1,1771,0827071,1691,8541,7701,5041,9161,7891,6111,2591,669
0.00.00.0−2760.00.00.00.00.00.00.0−195
8527865438831,3531,2921,2141,5751,3051,1759321,210
₹10.86₹9.77₹6.87₹10.96₹16.73₹16.07₹15.13₹19.45₹16.13₹14.58₹11.63₹14.81
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CIPLA₹1,365.60

Cipla Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersSUNPHARMADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹1.10L Cr
View
In ₹ Crore except Per Share
3 Months Ending
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Revenue from Operations6,603.86,163.26,693.97,051.07,073.06,729.76,957.57,589.47,074.56,541.27,119.37,403.9
Other Income184.6249.3160.2190.6221.6289.5258.6269.0206.3148.2210.9151.2
Total Income6,788.46,412.66,854.17,241.67,294.67,019.27,216.07,858.47,280.86,689.47,330.27,555.1
Expenses
+ Cost of Materials Consumed1,196.21,252.71,240.91,474.01,296.71,397.91,469.41,528.21,462.01,382.21,356.91,523.7
+ Purchases of Stock-in-Trade927.2739.01,100.0814.6913.21,023.71,025.0893.01,248.61,284.71,251.71,312.6
+ Changes in Inventories96.158.5-148.0-5.654.1-232.6-323.776.5-78.5-418.258.6-202.6
+ Employee Benefit Expense1,068.11,084.21,194.21,207.91,197.61,233.11,312.31,314.81,325.01,414.31,497.41,474.6
+ Finance Costs30.117.618.015.414.614.014.113.214.013.117.016.7
+ Depreciation & Amortisation233.4288.3246.7271.7279.8308.7252.7297.0278.4382.9304.2344.9
+ Other Expenses1,568.61,713.01,591.01,674.51,622.41,770.01,696.31,882.31,862.41,923.31,762.41,907.8
Total Expenses5,119.85,153.35,242.85,452.65,378.55,514.95,446.16,004.96,111.85,982.36,248.36,377.8
EBITDA1,747.51,315.91,715.81,885.61,988.91,537.61,778.11,894.81,255.1955.01,192.31,387.8
EBIT1,514.11,027.51,469.11,613.91,709.11,228.91,525.41,597.8976.7572.0888.11,042.9
Profit
PBT before Exceptional Items1,668.61,259.31,611.41,789.11,916.11,504.31,769.91,853.51,169.0707.11,081.91,177.3
+ Exceptional Items-194.80.00.00.00.00.00.00.0-275.90.00.00.0
Pretax Income1,473.81,259.31,611.41,789.11,916.11,504.31,769.91,853.5893.1707.11,081.91,177.3
+ Current Tax329.7511.1431.3459.0337.7480.4529.6468.4160.8282.2392.8372.3
+ Deferred Tax75.6-186.33.824.0-5.3-201.1-51.732.157.7-125.2-98.0-51.5
Tax Expense405.3324.9435.1483.0332.4279.3477.9500.5218.6157.0294.8320.8
+ Share of Associates & JVs-0.1-2.5-0.8-1.0-9.1-10.9-0.40.3-0.3-7.6-1.6-5.0
Net Income1,068.4931.91,175.51,305.01,574.61,214.11,291.61,353.4674.3542.5785.6851.5
+ Net Income — Continuing Ops1,068.5934.41,176.31,306.01,583.71,225.01,292.11,353.1674.6550.1787.1856.5
+ Other Comprehensive Income2.4-79.570.7131.2-37.754.581.4266.4204.1135.8194.1134.3
Total Comprehensive Income1,070.8852.41,246.21,436.21,536.91,268.61,373.01,619.8878.4678.3979.6985.8
Net Income to Common1,055.9939.01,177.61,302.51,570.51,221.81,297.61,351.2675.8554.6789.1877.5
Minority Interest12.5-7.2-2.22.54.1-7.7-6.02.2-1.6-12.1-3.5-26.0
Per Share
Basic EPS13.0811.6314.5816.1319.4515.1316.0716.738.376.879.7710.86
Diluted EPS13.0711.6214.5716.1219.4315.1216.0616.728.366.869.7610.85
Other Comprehensive Income — detail
+ Other Comprehensive Income—————54.581.4266.4204.1135.8194.1134.3
+ Items NOT to be Reclassified to P&L-1.5-52.7-6.2-6.0-1.6-52.3-8.5-0.0-2.4-178.024.3-2.0
+ Tax on Items NOT to be Reclassified—————-6.5-2.2-0.0-0.60.76.1-0.5
+ Tax on Items NOT to be Reclassified — alt tag-0.4-18.0-1.5-1.5-0.4———————
+ Items to be Reclassified to P&L2.5-43.372.4122.5-31.8113.086.1236.4203.7302.0188.7146.1
+ Tax on Items to be Reclassified—————12.8-1.7-30.0-2.3-12.512.810.3
+ Tax on Items to be Reclassified — alt tag-1.11.5-3.1-13.24.7———————
Comprehensive Income — Owners of Parent1,057.0860.01,248.61,433.01,533.21,274.81,378.81,617.4879.7692.1982.61,012.8
Comprehensive Income — Non-controlling Interests13.8-7.7-2.43.23.7-6.2-5.82.4-1.3-13.8-3.0-27.0
Per Share — as-filed variants
Basic EPS — Continuing Operations13.0811.6314.5816.1319.4515.1316.0716.738.376.879.7710.86
Diluted EPS — Continuing Operations13.0711.6214.5716.1219.4315.1216.0616.728.366.869.7610.85
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit4,384.34,113.14,501.14,768.04,808.94,540.74,786.85,091.84,442.44,292.54,452.14,770.2
Gross Margin %66.3966.7467.2467.6267.9967.4768.8067.0962.7965.6262.5464.43
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)1,668.61,259.31,611.41,789.11,916.11,504.31,769.91,853.51,169.0707.11,081.91,177.3
− Exceptional Items (reconciliation)-194.80.00.00.00.00.00.00.0-275.90.00.00.0
Net Income Adj (tax-effected)1,209.7931.91,175.51,305.01,574.61,214.11,291.61,353.4882.6542.5785.6851.5
EPS Adj14.8111.6314.5816.1319.4515.1316.0716.7310.966.879.7710.86
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.002.002.002.002.002.002.00
Paid Up Equity Capital161.5161.5161.5161.5161.5161.5161.6161.6161.6161.6161.6161.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Cipla Q2 FY27 results (July–September 2026)

Filed with NSE on Tuesday, 27 October 2026 at 1:31 pm IST

Cipla (NSE: CIPLA) reported its Q2 FY27 results (July–September 2026) on Tuesday, 27 October 2026 at 1:31 pm IST. Consolidated net profit attributable to shareholders was ₹878 crore, down 35.1% from ₹1,351 crore in Q2 FY26 and up 11.2% from ₹789 crore in Q1 FY27. Revenue from operations was ₹7,404 crore, down 2.4% year on year and up 4.0% from the previous quarter.

Q2 FY26 results (a year earlier)
30 October 2025
Q3 FY27 results due by
14 February 2027

Q2 FY27 at a glance · consolidated

Net profit (shareholders')
₹878 Cr−35.1% vs Q2 FY26+11.2% vs Q1 FY27Total incl. minority interest ₹852 Cr
Revenue from operations
₹7,404 Cr−2.4% vs Q2 FY26+4.0% vs Q1 FY27
Operating margin (EBIT)
14.1%−7.0 pts vs Q2 FY26+1.6 pts vs Q1 FY27EBIT ₹1,043 Cr
EBITDA
₹1,388 Cr−26.8% vs Q2 FY26+16.4% vs Q1 FY27margin 18.7%
Earnings per share (basic)
₹10.86−35.1% vs Q2 FY26+11.2% vs Q1 FY27
Net profit margin
11.9%−6.0 pts vs Q2 FY26+0.8 pts vs Q1 FY27

Questions

What was Cipla's net profit in Q2 FY27?

Consolidated net profit attributable to shareholders was ₹878 crore, down 35.1% from ₹1,351 crore in Q2 FY26 and up 11.2% from ₹789 crore in Q1 FY27. Including the minority shareholders' share, total profit was ₹852 crore.

How were Cipla's Q2 FY27 results?

Both fell from a year earlier: net profit was down 35.1% at ₹878 crore and revenue was down 2.4% at ₹7,404 crore. The operating margin was 14.1%, down 7.0 percentage points from 21.1% a year earlier. Against Q1 FY27, net profit was up 11.2% and revenue up 4.0%.

What was Cipla's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹1,043 crore, a margin of 14.1%, against 12.5% in Q1 FY27 and 21.1% in Q2 FY26. EBITDA was ₹1,388 crore, 18.7% of revenue.

What was Cipla's revenue in Q2 FY27?

Revenue from operations was ₹7,404 crore, down 2.4% year on year and up 4.0% from the previous quarter.

What was Cipla's EPS in Q2 FY27?

Basic earnings per share were ₹10.86, against ₹16.73 in Q2 FY26.

When did Cipla announce its Q2 FY27 results?

On Tuesday, 27 October 2026 at 1:31 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 30 October 2025.

What was Cipla's net profit in the first half of FY27?

Consolidated net profit attributable to shareholders for the first half of FY27 (April–September 2026) was ₹1,667 crore, down 37.1% from ₹2,649 crore in the same months a year earlier. Revenue from operations was ₹14,523 crore, down 0.2%.

What was Cipla's net profit in FY26?

Consolidated net profit attributable to shareholders was ₹3,879 crore in FY26 (April 2025–March 2026), down 26.4% from ₹5,273 crore in FY25. It was ₹4,122 crore in FY24 and ₹2,802 crore in FY23: up 38.4% over three years, 11.5% a year on average.

When will Cipla announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

What is Cipla's net profit margin?

Cipla's net profit margin was 11.9% in Q2 FY27 (net profit attributable to shareholders as a share of revenue from operations), against 17.8% in Q2 FY26 (down 6.0 percentage points). For FY26 as a whole it was 13.8%.

How has Cipla's profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: ₹676 crore in Q3 FY26, ₹555 crore in Q4 FY26, ₹789 crore in Q1 FY27 and ₹878 crore in Q2 FY27. That is ₹2,897 crore over the four quarters, down 46.8% from ₹5,441 crore in the four quarters before. Revenue from operations: ₹7,074 crore, ₹6,541 crore, ₹7,119 crore and ₹7,404 crore.

What was Cipla's revenue in FY26?

Revenue from operations was ₹28,163 crore in FY26 (April 2025–March 2026), up 2.2% from ₹27,548 crore in FY25. It was ₹25,774 crore in FY24 and ₹22,753 crore in FY23: up 23.8% over three years, 7.4% a year on average.

Where do these Cipla figures come from?

From Cipla's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 27 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.